OASIS-E Spotlight: Patient Mood Interview

August 14, 2023

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy.

D0150: Patient Mood Interview (PHQ 2-9)

D0150 is intended to identify the “signs and symptoms of mood distress”. Per the CMS OASIS-E Guidance Manual it is “a serious condition that is underdiagnosed and undertreated in home health and is associated with significant morbidity.”

The PHQ2-9 is a “validated interview that screens for symptoms of depression. It provides a standardized severity score and a rating for evidence of a depressive disorder.”

Additional guidance from the OASIS-E manual includes:

    • Conduct the interview in a private setting, if possible.
    • Interact with the patient using their preferred language.
    • Explain the reason for the interview before beginning.
    • Do not provide definitions because the meaning must be based on the patient’s interpretation.
    • Each question must be asked in sequence.

Time points:

    • Start of Care
    • Resumption of Care
    • Discharge from agency

D0150: Patient Mood Interview (PHQ 2-9)

Say to the patient: “Over the last 2 weeks, have you been bothered by any of the following problems?”

If the symptom is present, enter 1 (yes) in column 1, Symptom Presence
If yes in column 1, then ask the patient: “About how often have you been bothered by this?”
Read and show the patient a card with the symptom frequency choices. Indicate a response in column 2, Symptom Frequency

SYMPTOM PRESENCE:
Dash is a valid response for this item. Enter a Dash in Column 1 if the symptom presence was not assessed. Leave Column 2, Symptom Frequency, blank.

SYMPTOM FREQUENCY:
Dash is not a valid response for this item.

1. Symptom Presence
Code 0, No (enter 0 in column 2)
Code 1, Yes (enter 0-3 in column 2)
Code 9, No response (leave column 2 blank)

2. Symptom Frequency
Code 0, Never or 1 day
Code 1, 2-6 days (several days)
Code 2, 7-11 days (half or more of the days)
Code 3, 12-14 days (nearly every day)

Copyright  Pfizer Inc. All rights reserved. Reproduced for OASIS by permission.

Next time we’ll look at scoring for the PHQ2-9.

Stay tuned for next Monday’s spotlight so your practice can continue to stay ahead of the curve and provide elite patient care through the Oasis E changes.

We provide clinicians that are part of the Kantime enterprise system with links to the guidance from CMS for each individual OASIS item. If you would like to learn more about how better happens, contact us at sales@kanrad.com to schedule a demo.

Ready to see How better Happens?

Request a Demo

We Think You May Also Like

BLOG

OASIS-E Spotlight: Special Treatments, Procedures, and Programs

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy. O0110: […]

BLOG

OASIS-E Spotlight: Transportation (NACHC)

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy. A1250: […]

BLOG

OASIS-E Spotlight: High-Risk Drug Classes: Use and Indication

Making sense of CMS guidelines is more challenging than ever after the launch of OASIS-E and the abundance of changes that go along with it. KanTime’s OASIS Spotlight series will spotlight specific OASIS items to simplify the ruling and help clinicians significantly improve their understanding of OASIS so they can move forward with accuracy. K0415: […]